← Open Payments lookup

HOLLY ACKERMANN: Open Payments

NPI 1003303389 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,431 in 84 payments from 22 companies in 2025. Trend: 2023 $1,475 · 2024 $1,463 · 2025 $1,431

Food & beverage: $1,392Education: $39
CompanyPaymentsAmount
ABBVIE INC.33$444
AstraZeneca Pharmaceuticals LP11$204
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$143
Novo Nordisk Inc5$102
Otsuka America Pharmaceutical, Inc.3$63
PFIZER INC.3$60
Amgen Inc.3$46
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$42
Exact Sciences Corporation2$39
Lilly USA, LLC2$39

Products named: VRAYLAR, CAPLYTA, UBRELVY, REXULTI, QULIPTA, AIRSUPRA, FARXIGA, NURTEC ODT.

Industry payments across MO — which companies pay providers there.